{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:48:36Z","timestamp":1785163716140,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021820","name":"Prinses M\u00e1xima Centrum Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021820","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201191","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:22:42Z","timestamp":1774930962000},"page":"201191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3623-0348","authenticated-orcid":false,"given":"Konstantinos","family":"Vazaios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Tallon-Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa P.J.","family":"van Oosterhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Waranecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelisa M.","family":"Cornel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl M.M.","family":"Dautzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marliek","family":"van Hoesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob C.","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"van der Lugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friso G.","family":"Calkoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Hulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201191_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.omton.2026.201191_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/2159-8290.CD-21-1094","article-title":"A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era","volume":"12","author":"Pfister","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2026.201191_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/jpm12071050","article-title":"The Current State of Radiotherapy for Pediatric Brain Tumors: An Overview of Post-Radiotherapy Neurocognitive Decline and Outcomes","volume":"12","author":"Major","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.omton.2026.201191_bib4","first-page":"5","article-title":"Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015\u20132019","volume":"11","author":"Price","year":"2024","journal-title":"Neurooncol. Pract."},{"key":"10.1016\/j.omton.2026.201191_bib5","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201191_bib6","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201191_bib7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","volume":"31","author":"Vitanza","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201191_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201191_bib9","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1038\/s41467-024-49595-1","article-title":"Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment","volume":"15","author":"Levine","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201191_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.trecan.2023.07.007","article-title":"CAR T cell therapies for diffuse midline glioma","volume":"9","author":"Thomas","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.omton.2026.201191_bib11","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.3390\/cancers14205108","article-title":"Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors","volume":"14","author":"Boccalatte","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2026.201191_bib12","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.3390\/ijms25095007","article-title":"OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions","volume":"25","author":"Vazaios","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2026.201191_bib13","article-title":"The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles","volume":"32","author":"Vazaios","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.omton.2026.201191_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201191_bib15","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma","volume":"386","author":"G\u00e1llego P\u00e9rez-Larraya","year":"2022","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.omton.2026.201191_bib16","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1158\/0008-5472.CAN-14-0697","article-title":"Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors","volume":"74","author":"Nishio","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2026.201191_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/hum.2021.216","article-title":"Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates","volume":"33","author":"Bots","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omton.2026.201191_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048064","article-title":"Isolation of Reovirus T3D Mutants Capable of Infecting Human Tumor Cells Independent of Junction Adhesion Molecule-A","volume":"7","author":"van den Wollenberg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201191_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201191_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02478920","article-title":"Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines","volume":"18","author":"Sasaki","year":"2001","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.omton.2026.201191_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2008.04.029","article-title":"Chemokine production and chemokine receptor expression by human glioma cells: Role of CXCL10 in tumour cell proliferation","volume":"199","author":"Maru","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.omton.2026.201191_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OV.S143808","article-title":"Current understanding of reovirus oncolysis mechanisms","volume":"7","author":"Phillips","year":"2018","journal-title":"Oncolytic Virother."},{"key":"10.1016\/j.omton.2026.201191_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2005.08.023","article-title":"Modulation of host cell gene expression during onset of the late phase of an adenovirus infection is focused on growth inhibition and cell architecture","volume":"343","author":"Granberg","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.omton.2026.201191_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/msystems.00468-21","article-title":"Adenovirus Remodeling of the Host Proteome and Host Factors Associated with Viral Genomes","volume":"6","author":"Dybas","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.omton.2026.201191_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1484241","article-title":"Cellular SUMO-specific proteases regulate HAdV-C5 E1B-55K SUMOylation and virus-induced cell transformation","volume":"14","author":"Ip","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omton.2026.201191_bib26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1006\/viro.1997.8664","article-title":"Double-Stranded RNA-Dependent Protein Kinase (PKR) Is Regulated by Reovirus Structural Proteins","volume":"234","author":"Yue","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.omton.2026.201191_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-Stimulated Genes: A Complex Web of Host Defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201191_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-012-1021-2","article-title":"B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma","volume":"111","author":"Zhou","year":"2013","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.omton.2026.201191_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99573","article-title":"Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses","volume":"3","author":"Watanabe","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.omton.2026.201191_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/v15020283","article-title":"Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus \u2018GoraVir\u2019 in Cultured Pancreatic Cancer Cells","volume":"15","author":"Bots","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.omton.2026.201191_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011783","article-title":"hCCL19-expressing recombinant Newcastle disease virus boosts CAR T cell infiltration and efficacy in solid tumor","volume":"13","author":"Liu","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2026.201191_bib32","article-title":"Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma","volume":"33","author":"Arias","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.omton.2026.201191_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1182\/blood-2023-179480","article-title":"Single-Cell Multi-Omics Reveals Type-2 Functionality in Maintaining CAR T Cell Longevity Associated with 8-Year Leukemia Remission","volume":"142","author":"Bai","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201191_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114551","article-title":"Activation phenotypes defined by the coordinated expression of activation markers discriminate TCR-mediated and bystander T cell responses","volume":"29","author":"Schenk","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.omton.2026.201191_bib35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/imm.12890","article-title":"Acute stimulation generates Tim-3-expressing T helper type 1 CD 4 T cells that persist in vivo and show enhanced effector function","volume":"154","author":"Gorman","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.omton.2026.201191_bib36","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omton.2026.201191_bib37","doi-asserted-by":"crossref","first-page":"513","DOI":"10.14348\/molcells.2022.2056","article-title":"Current Understanding of Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Signaling in T-Cell Biology and Disease Therapy","volume":"45","author":"Kim","year":"2022","journal-title":"Mol. Cells"},{"key":"10.1016\/j.omton.2026.201191_bib38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/mt.2014.160","article-title":"CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy","volume":"22","author":"Engeland","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omton.2026.201191_bib39","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.2200578","article-title":"Cutting Edge: CCR9 Promotes CD8+ T Cell Recruitment to the Brain during Congenital Cytomegalovirus Infection","volume":"209","author":"Hilt","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201191_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734871","article-title":"Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV Infection","volume":"12","author":"Olwenyi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201191_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/imm.12250","article-title":"Increased numbers and functional activity of CD56+ T cells in healthy cytomegalovirus positive subjects","volume":"142","author":"Almehmadi","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.omton.2026.201191_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.immuni.2015.02.009","article-title":"CXCR3 Chemokine Receptor Enables Local CD8+ T Cell Migration for the Destruction of Virus-Infected Cells","volume":"42","author":"Hickman","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2026.201191_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjh.17034","article-title":"Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients","volume":"191","author":"Bellesi","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2026.201191_bib44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004464","article-title":"Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy","volume":"10","author":"Groeneveldt","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2026.201191_bib45","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/cgt.2011.90","article-title":"Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells","volume":"19","author":"Gao","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omton.2026.201191_bib46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tranon.2017.10.005","article-title":"Chimeric HCMV\/HSV-1 and \u0394\u03b3(1)34.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory","volume":"11","author":"Ghonime","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.omton.2026.201191_bib47","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41590-023-01453-w","article-title":"IFN\u03b3-induction of TH1-like regulatory T cells controls antiviral responses","volume":"24","author":"Gocher-Demske","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201191_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.omto.2021.11.020","article-title":"Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory","volume":"24","author":"Veinalde","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omton.2026.201191_bib49","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1038\/s41467-020-18070-y","article-title":"Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity","volume":"11","author":"Grabovska","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201191_bib50","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.3390\/cancers13225601","article-title":"The Growing Relevance of Immunoregulation in Pediatric Brain Tumors","volume":"13","author":"Melcher","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.omton.2026.201191_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fonc.2015.00172","article-title":"Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma","volume":"5","author":"Misuraca","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201191_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","article-title":"Humanized mouse models for immuno-oncology research","volume":"20","author":"Chuprin","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201191_bib53","article-title":"An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma","volume":"4","author":"Stavrakaki","year":"2024","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.omton.2026.201191_bib54","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/neuonc\/noy082","article-title":"Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment","volume":"20","author":"van den Bossche","year":"2018","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.omton.2026.201191_bib55","article-title":"CAR T-cell and oncolytic virus dynamics and determinants of combination therapy success for glioblastoma","author":"Conte","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.omton.2026.201191_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.yexcr.2017.09.032","article-title":"Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies","volume":"360","author":"Meel","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omton.2026.201191_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2026.201191_bib58","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1158\/1535-7163.MCT-15-0558","article-title":"Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models","volume":"15","author":"Jansen","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omton.2026.201191_bib59","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/NEN.0000000000000216","article-title":"Disrupting NOTCH Slows Diffuse Intrinsic Pontine Glioma Growth, Enhances Radiation Sensitivity, and Shows Combinatorial Efficacy With Bromodomain Inhibition","volume":"74","author":"Taylor","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omton.2026.201191_bib60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.omtm.2021.03.015","article-title":"Efficient lentiviral transduction method to gene modify cord blood CD8+ T cells for cancer therapy applications","volume":"21","author":"Lo Presti","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omton.2026.201191_bib61","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.omton.2026.201191_bib62","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol. Biosyst."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:18:04Z","timestamp":1783325884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926000676"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201191","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Boosting CAR T cell functionality with oncolytic viruses for the treatment of pediatric diffuse midline gliomas","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201191"}}